Aardvark Therapeutics (AARD) Shares Issued (2024 - 2025)
Aardvark Therapeutics (AARD) posted Shares Issued of $3.0 million for Q4 2025, up 206.58% sequentially from $991058.0 in Q4 2024, and up 206.58% YoY from $991058.0 in Q4 2024.
Aardvark Therapeutics (AARD) Shares Issued (2024 - 2025) Analysis & Trends
Aardvark Therapeutics has reported Shares Issued for 2 years, with the latest figure at $3.0 million in Q4 2025.
- Quarterly Shares Issued rose 206.58% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 206.58% YoY) and the FY2025 annual result came in at $3.0 million, up 206.58% from the prior year.
- Shares Issued advanced to $3.0 million in Q4 2025 per AARD's latest filing, from $991058.0 in the prior quarter.
- Over five years, Shares Issued peaked at $3.0 million in Q4 2025 and troughed at $991058.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Aardvark Therapeutics | 148.55 Mn | 74.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 991,058.00 |
| Dec 31, 2024 | 991,058.00 |